| http://www.w3.org/ns/prov#value | - er proliferative diseases and conditions such as restenosis and polycystic kidney disease, and any other cancer or proliferative disease or condition that can respond to the level of ICAM in a cell or tissue, alone or in combination with other therapies.
|
